Alternatives for Reducing Tics in Tourette Syndrome (TS): A Study of TEV-50717 (Deutetrabenazine) for the Treatment of Tourette Syndrome in Children and Adolescents

Exclusion Criteria

• •Participant has a neurologic disorder other than TS that could obscure the evaluation of tics.
• •Participant has a confirmed diagnosis of bipolar disorder, schizophrenia, or another psychotic disorder.
• •Participant has clinically significant depression at screening or baseline.
• •Participant has a history of suicidal intent or related behaviors within 2 years of screening.
• •Participant has a history of a previous actual, interrupted, or aborted suicide attempt.
• •Participant has a first-degree relative who has completed suicide.
• •Participant has received comprehensive behavioral intervention for tics (CBIT) for TS or cognitive behavioral therapy (CBT) for obsessive-compulsive disorder (OCD) within 4 weeks of screening.
• •Participant has an unstable or serious medical illness at screening or baseline.
• •Participant is pregnant or breastfeeding.
• •* Additional criteria apply, please contact the investigator for more information.